These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 33187885)
1. Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival. Volz Y; Grimm T; Ormanns S; Eismann L; Pfitzinger PL; Jokisch JF; Schulz G; Casuscelli J; Schlenker B; Karl A; Stief CG; Kretschmer A Urol Oncol; 2021 May; 39(5):299.e15-299.e21. PubMed ID: 33187885 [TBL] [Abstract][Full Text] [Related]
2. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387 [TBL] [Abstract][Full Text] [Related]
3. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404 [TBL] [Abstract][Full Text] [Related]
4. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844 [TBL] [Abstract][Full Text] [Related]
5. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes. Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764 [TBL] [Abstract][Full Text] [Related]
7. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. Evers PD; Logan JE; Sills V; Chin AI World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy. Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857 [TBL] [Abstract][Full Text] [Related]
9. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013. Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867 [TBL] [Abstract][Full Text] [Related]
10. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer. Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045 [TBL] [Abstract][Full Text] [Related]
11. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer. Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162 [TBL] [Abstract][Full Text] [Related]
12. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. Soave A; John LM; Dahlem R; Minner S; Engel O; Schmidt S; Kluth LA; Fisch M; Rink M Urology; 2015 Jul; 86(1):92-8. PubMed ID: 26051839 [TBL] [Abstract][Full Text] [Related]
13. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches. Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782 [TBL] [Abstract][Full Text] [Related]
14. The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre. Naspro R; Finati M; Roscigno M; Pellucchi F; La Croce G; Sodano M; Manica M; Chinaglia D; Da Pozzo LF World J Urol; 2021 Jun; 39(6):1917-1926. PubMed ID: 32696127 [TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder. Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195 [TBL] [Abstract][Full Text] [Related]
16. [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]. May M; Fritsche HM; Gilfrich C; Brookman-May S; Burger M; Otto W; Bolenz C; Trojan L; Herrmann E; Michel MS; Wülfing C; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Müller O; Bretschneider-Ehrenberg P; Zacharias M; Gunia S; Bastian PJ Urologe A; 2011 Jul; 50(7):821-9. PubMed ID: 21340593 [TBL] [Abstract][Full Text] [Related]
17. Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. da Silva RD; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Chade D; Guglielmetti GB; Pycha A; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Zerbib M; Scherr DS; Shariat SF J Urol; 2013 Aug; 190(2):487-92. PubMed ID: 23395802 [TBL] [Abstract][Full Text] [Related]
18. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis. Wang JK; Boorjian SA; Cheville JC; Kim SP; Tarrell RF; Thapa P; Frank I World J Urol; 2012 Dec; 30(6):801-6. PubMed ID: 23132611 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418 [TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation. Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]